Johnson & Johnson is warning diabetes patients of a defect with one of its insulin pumps which could theoretically allow hackers to access to the pump and maliciously overdose patients with insulin.

Johnson & Johnson's Animas Corp. will close and exit the insulin pump business, the company said Thursday, citing increased competition that made selling the pumps unsustainable. Sales of its Animas ...

MILWAUKEE, June 10, 2025 /PRNewswire/ -- Johnson Controls commercial heat pumps are delivering competitive advantage to customers and partners across all industries – from global industrial and ...

The Animas OneTouch Ping insulin pump contains vulnerabilities that could be exploited by a malicious attacker to remotely trigger an insulin injection. Security researcher Jay Radcliffe – who is ...

Abiomed, also now known as Johnson & Johnson MedTech, issued a recall for its Impella RP with SmartAssist and Impella RP Flex with SmartAssist heart pumps due to safety concerns. The recall involves ...

(Reuters) - Johnson & Johnson's diabetes care unit, which makes insulin pumps, said on Thursday it would shut its business in United States and Canada amid increased competition and after failing to ...

This article first appeared on GuruFocus. Johnson & Johnson (NYSE:JNJ) says a tiny heart pump could give heart attack survivors a real shot at longer lives. In results from its 10-year DanGer Shock ...

Johnson & Johnson’s Animas Corp. will close and exit the insulin pump business, the company said Thursday, citing increased competition that made selling the pumps unsustainable. Sales of its Animas ...